title: Asymptomatic pulmonary cryptococcosis in a patient with Crohn's disease on infliximab: case report.
authors.forename: Fumihito
authors.initials: F
authors.lastname: Hirai
authors.forename: Toshiyuki
authors.initials: T
authors.lastname: Matsui
authors.forename: Yukiko
authors.initials: Y
authors.lastname: Ishibashi
authors.forename: Daijirou
authors.initials: D
authors.lastname: Higashi
authors.forename: Kitarou
authors.initials: K
authors.lastname: Futami
authors.forename: Seiji
authors.initials: S
authors.lastname: Haraoka
authors.forename: Akinori
authors.initials: A
authors.lastname: Iwashita
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D058070:Asymptomatic Diseases; D003453:Cryptococcosis / Q000139:chemically induced* / Q000175:diagnosis / Q000382:microbiology; D003455:Cryptococcus neoformans / Q000472:pathogenicity*; D006801:Humans; D000069285:Infliximab; D008172:Lung Diseases, Fungal / Q000139:chemically induced* / Q000175:diagnosis / Q000382:microbiology; D008297:Male; D011379:Prognosis; D014057:Tomography, X-Ray Computed; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000276:immunology
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab